omim.org

Online Mendelian Inheritance in Man (OMIM)

  • ️Tue Mar 25 2014

  1. Allayee, H., Aouizerat, B. E., Cantor, R. M., Dallinga-Thie, G. M., Krauss, R. M., Lanning, C. D., Rotter, J. I., Lusis, A. J., de Bruin, T. W. A. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype. Am. J. Hum. Genet. 63: 577-585, 1998. [PubMed: 9683614] [Full Text: https://doi.org/10.1086/301983]

  2. Allayee, H., Castellani, L. W., Cantor, R. M., de Bruin, T. W. A., Lusis, A. J. Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia. Circ. Res. 92: 1262-1267, 2003. [PubMed: 12738753] [Full Text: https://doi.org/10.1161/01.RES.0000075600.87675.16]

  3. Aouizerat, B. E., Allayee, H., Cantor, R. M., Davis, R. C., Lanning, C. D., Wen, P.-Z., Dallinga-Thie, G. M., de Bruin, T. W. A., Rotter, J. I., Lusis, A. J. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11. Am. J. Hum. Genet. 65: 397-412, 1999. [PubMed: 10417282] [Full Text: https://doi.org/10.1086/302490]

  4. Babirak, S. P., Iverius, P.-H., Fujimoto, W. Y., Brunzell, J. D. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 9: 326-334, 1989. [PubMed: 2719595] [Full Text: https://doi.org/10.1161/01.atv.9.3.326]

  5. Bello-Chavolla, O. Y., Kuri-Garcia, A., Rios-Rios, M., Vargas-Vazquez, A., Cortes-Arroyo, J. E., Tapia-Gonzalez, G., Cruz-Bautista, I., Aguilar-Salinas, C. A. Familial combined hyperlipidemia: current knowledge, perspectives, and controversies. Rev. Invest. Clin. 70: 224-236, 2018. [PubMed: 30307446] [Full Text: https://doi.org/10.24875/RIC.18002575]

  6. Bodnar, J. S., Chatterjee, A., Castellani, L. W., Ross, D. A., Ohmen, J., Cavalcoli, J., Wu, C., Dains, K. M., Catanese, J., Chu, M., Sheth, S. S., Charugundla, K., Demant, P., West, D. B., de Jong, P., Lusis, A. J. Positional cloning of the combined hyperlipidemia gene Hyplip1. Nature Genet. 30: 110-116, 2002. [PubMed: 11753387] [Full Text: https://doi.org/10.1038/ng811]

  7. Brahm, A. J., Hegele, R. A. Combined hyperlipidemia: familial but not (usually) monogenic. Curr. Opin. Lipidol. 27: 131-140, 2016. [PubMed: 26709473] [Full Text: https://doi.org/10.1097/MOL.0000000000000270]

  8. Bredie, S. J. H., Demacker, P. N. M., Stalenhoef, A. F. H. Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity. Europ. J. Clin. Invest. 27: 802-811, 1997. [PubMed: 9373757] [Full Text: https://doi.org/10.1046/j.1365-2362.1997.1850734.x]

  9. Bredie, S. J. H., Kiemeney, L. A., de Haan, A. F. J., Demacker, P. N. M., Stalenhoef, A. F. H. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia. Am. J. Hum. Genet. 58: 812-822, 1996. [PubMed: 8644746]

  10. Brunzell, J. D., Albers, J. J., Chait, A., Grundy, S. M., Groszek, E., McDonald, G. B. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J. Lipid Res. 24: 147-155, 1983. [PubMed: 6403642]

  11. Brunzell, J. D., Schrott, H. G., Motulsky, A. G., Bierman, E. L. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 25: 313-320, 1976. [PubMed: 1250165] [Full Text: https://doi.org/10.1016/0026-0495(76)90089-5]

  12. Chait, A., Brunzell, J. D. Severe hypertriglyceridemia: role and familial and acquired disorders. Metabolism 32: 209-214, 1983. [PubMed: 6827992] [Full Text: https://doi.org/10.1016/0026-0495(83)90184-1]

  13. Geurts, J. M. W., Janssen, R. G. J. H., van Greevenbroek, M. M. J., van der Kallen, C. J. H., Cantor, R. M., Bu, X., Aouizerat, B. E., Allayee, H., Rotter, J. I., de Bruin, T. W. A. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia. Hum. Molec. Genet. 9: 2067-2074, 2000. [PubMed: 10958645] [Full Text: https://doi.org/10.1093/hmg/9.14.2067]

  14. Glueck, C. J., Fallat, R., Buncher, C. R., Tsang, R., Steiner, P. M. Familial combined hyperlipoproteinemia: studies in 91 adults and 95 children from 33 kindreds. Metabolism 22: 1403-1428, 1973. [PubMed: 4356145] [Full Text: https://doi.org/10.1016/0026-0495(73)90256-4]

  15. Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., Motulsky, A. G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest. 52: 1544-1568, 1973. [PubMed: 4718953] [Full Text: https://doi.org/10.1172/JCI107332]

  16. Hayden, M. R., Kirk, H., Clark, C., Frohlich, J., Rabkin, S., McLeod, R., Hewitt, J. DNA polymorphisms in and around the Apo-AI-CIII genes and genetic hyperlipidemias. Am. J. Hum. Genet. 40: 421-430, 1987. [PubMed: 2883893]

  17. Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., Breslow, J. L. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249: 790-793, 1990. [PubMed: 2167514] [Full Text: https://doi.org/10.1126/science.2167514]

  18. Juo, S.-H. H., Bredie, S. J. H., Kiemeney, L. A., Demacker, P. N. M., Stalenhoef, A. F. H. A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia. Am. J. Hum. Genet. 63: 586-594, 1998. [PubMed: 9683593] [Full Text: https://doi.org/10.1086/301962]

  19. Kissebah, A. H., Alfarsi, S., Evans, D. J. Low density lipoprotein metabolism in familial combined hyperlipidemia: mechanism of the multiple lipoprotein phenotypic expression. Arteriosclerosis 4: 614-624, 1984. [PubMed: 6508636] [Full Text: https://doi.org/10.1161/01.atv.4.6.614]

  20. Masucci-Magoulas, L., Goldberg, I. J., Bisgaier, C. L., Serajuddin, H., Francone, O. L., Breslow, J. L., Tall, A. R. A mouse model with features of familial combined hyperlipidemia. Science 275: 391-394, 1997. [PubMed: 8994037] [Full Text: https://doi.org/10.1126/science.275.5298.391]

  21. Nishina, P. M., Johnson, J. P., Naggert, J. K., Krauss, R. M. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc. Nat. Acad. Sci. 89: 708-712, 1992. [PubMed: 1731344] [Full Text: https://doi.org/10.1073/pnas.89.2.708]

  22. Pajukanta, P., Allayee, H., Krass, K. L., Kuraishy, A., Soro, A., Lilja, H. E., Mar, R., Taskinen, M.-R., Nuotio, I., Laakso, M., Rotter, J. I., de Bruin, T. W. A., Cantor, R. M., Lusis, A. J., Peltonen, L. Combined analysis of genome scans of Dutch and Finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q. Am. J. Hum. Genet. 72: 903-917, 2003. [PubMed: 12638083] [Full Text: https://doi.org/10.1086/374177]

  23. Rauh, G., Schuster, H., Muller, B., Schewe, S., Keller, C., Wolfram, G., Zollner, N. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia. Atherosclerosis 83: 81-87, 1990. [PubMed: 1975179] [Full Text: https://doi.org/10.1016/0021-9150(90)90133-4]

  24. Rose, H. G., Kranz, P., Weinstock, M., Juliano, J., Haft, J. I. Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype. Am. J. Med. 54: 148-160, 1973. [PubMed: 4346680] [Full Text: https://doi.org/10.1016/0002-9343(73)90218-0]

  25. Rotter, J. I., Bu, X., Cantor, R. M., Warden, C. H., Brown, J., Gray, R. J., Blanche, P. J., Krauss, R. M., Lusis, A. J. Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am. J. Hum. Genet. 58: 585-594, 1996. [PubMed: 8644718]

  26. Tas, S. Strong association of a single nucleotide substitution in the 3-prime-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs. Clin. Chem. 35: 256-259, 1989. [PubMed: 2914370]

  27. van der Vleuten, G. M., Hijmans, A., Kluijtmans, L. A. J., Blom, H. J., Stalenhoef, A. F. H., de Graaf, J. Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia. Am. J. Med. Genet. 130A: 73-75, 2004. [PubMed: 15368498] [Full Text: https://doi.org/10.1002/ajmg.a.30036]

  28. Wijsman, E. M., Brunzell, J. D., Jarvik, G. P., Austin, M. A., Motulsky, A. G., Deeb, S. S. Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex. Arterioscler. Thromb. Vasc. Biol. 18: 215-226, 1998. [PubMed: 9484986] [Full Text: https://doi.org/10.1161/01.atv.18.2.215]

  29. Wojciechowski, A. P., Farrall, M., Cullen, P., Wilson, T. M. E., Bayliss, J. D., Farren, B., Griffin, B. A., Caslake, M. J., Packard, C. J., Shepherd, J., Thakker, R., Scott, J. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-q24. Nature 349: 161-164, 1991. [PubMed: 1670899] [Full Text: https://doi.org/10.1038/349161a0]

  30. Xu, C.-F., Talmud, P., Schuster, H., Houlston, R., Miller, G., Humphries, S. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia. Clin. Genet. 46: 385-397, 1994. [PubMed: 7889654] [Full Text: https://doi.org/10.1111/j.1399-0004.1994.tb04404.x]

  31. Yang, W.-S., Nevin, D. N., Peng, R., Brunzell, J. D., Deeb, S. S. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc. Nat. Acad. Sci. 92: 4462-4466, 1995. Note: Erratum: Proc. Nat. Acad. Sci. 93: 524 only, 1996. [PubMed: 7753827] [Full Text: https://doi.org/10.1073/pnas.92.10.4462]